Comprehensive Stool Analysis: The Wrong Enemy on the Report

A comprehensive stool analysis can name organisms correctly and still point at the wrong enemy. The fungi and parasites it flags are common in people who feel well. And its diversity score added nothing to standard risk factors in predicting death. Measure what the community is doing instead. Use breath hydrogen and methane, an inflammation marker and a food record.

A man of thirty-nine brings in a glossy printout with two lines marked in yellow. He has spent two years and real money on those lines. He did three antifungal protocols and two rounds of herbal antimicrobials. He took a course of metronidazole from an online visit. He followed a diet with fourteen banned foods. He still bloats and he is still tired. His comprehensive stool analysis was not wrong. It was answering a question that cannot fix him.

The chapter video, The Wrong Enemy on Your Stool Report, carries the core argument from The Angry Gut, by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. Here is the measuring half. What can a panel prove? What does a diversity number predict? And what has actually been shown to rebuild a terrain?

Is a comprehensive stool test worth it?

Hunt for common organisms in people unlikely to be sick, and you find more of them. The number of people helped stays flat. A children’s hospital network swapped standard stool testing for a multiplex PCR panel. Positive results climbed to 40% from 11%. They came back in 4 hours instead of 31. Children treated for a bacterial or parasitic germ went home two days sooner. But they were 3% of those tested. Across the whole group there was no difference in length of stay, extra testing or charges. The authors called it low-value care. And this was a before-and-after design, not a study of accuracy.

Sixty-nine specialists reached the same place in a consensus statement. They wrote that consumer microbiome tests are sold “without any consensus on their regulation or any proven value in clinical practice.” Expert opinion is not data. It is also the only professional standard that exists here. Getting the same answer twice is its own problem: why one stool sample can return several different answers.

Why does a fungal result on a stool test not repeat?

Before acting on a fungal line, ask whether the same person would produce it twice. Fungi in stool have been traced back to the mouth and the plate, not to a colony living in the bowel. Between 0.01% and 0.1% of gene reads from adult stool map to fungal species. That is a rounding error next to a load counted in trillions. And fungi would not grow on a medium that supports nearly every bacterial species found there. Two details bring it home. Levels of C. albicans in stool dropped sharply with more frequent tooth brushing. And in one volunteer, an accidental piece of bread pushed baker’s yeast back to 16% of fungal reads within a day. Brushing your teeth moves your result. So does breakfast on collection morning.

Four volunteers on a controlled diet is a small study. Those authors drew the line themselves: fungi do cause serious infections in people with weak immune systems.

What does the diversity score on a comprehensive stool analysis predict?

The number everyone reaches for does not do what they think. In a Finnish death study, gut makeup alone predicted death with a C-statistic of 0.634. Ordinary clinical risk factors reached 0.798. Adding the microbiome to those risk factors moved the number to 0.796. That is nothing, at a P of 0.11. The part carrying the whole signal explained 1.4% of the difference between people. Its top quarter ran a 49% greater risk of death than its bottom quarter. That sounds huge until you see how little of anyone’s gut it describes.

Then there is the confounder that never shows on a report. In 53 healthy women, stool firmness tracked with every known major microbiome marker. It ran against species richness. Faster transit favored fast-growing species. So a low richness score may just report how fast things move through you. Richness also swings with the calendar. Across a year of Hadza stool samples, some groups vanished and came back in a later season. Test in the wrong month and you look depleted.

So a high count is not a verdict and a low count is not a diagnosis. Diversity is what a gut looks like when the terrain is working. It is not the lever that makes it work. It is the same rule as making every marker in a workup earn its place before anyone treats it.

An old friend, subtyped

The protozoan on his report has subtypes, and they are not interchangeable. In Italy, 2,524 people were sent for parasite testing. Microscopy found Blastocystis in 192, or 7.6%. Subtype 3 made up 40% of them, and those carriers had higher bacterial diversity. Read the next line twice. A high percentage of Enterobacteriaceae was found in the people who carried no Blastocystis at all. The family that predicts death was more common in the people whose test came back clean.

Microscopy is far less sensitive than PCR. So 7.6% is a floor, not the true rate. And all of this is association. A large metabolic study points at the likely reason. Those microbe links were driven especially by eating healthy, plant-based foods, and a variety of them. The organism may be riding on the diet. That study ran through a commercial nutrition company with an interest in such advice.

A marker of a good gut is not a treatment target. It is a receipt.

What actually rebuilds a gut bacterial community?

Food has the better evidence. And the trial testing it is more honest than the marketing around it. Healthy adults were randomly assigned to add either 20 grams of fiber a day or 6 servings a day of fermented foods for 10 weeks. The main planned outcome, a cytokine response score, was not significant in either arm. Among the side findings, 19 of 93 inflammatory blood proteins fell in the fermented arm, including IL-6. None moved with fiber. Fiber instead raised the community’s power to break down carbs, while diversity stayed flat. The arms were small, there was no blinding, and everything was secondary to a null main result. The shape is still the practical answer. Feeding a community changes what it does before it changes who belongs to it. And neither arm needed a kill.

After antibiotics the instinct is a capsule, and that was tested directly. Probiotics led to a much slower and still incomplete return of a person’s own community. Putting back that person’s own banked stool restored it within days. The gut’s defense against invaders also breaks under proton pump inhibitors, diabetes drugs and antipsychotics. So a medication list often explains more than a panel does. It is the same terrain argument that decides why one person heals from a procedure and another does not.

What I told him, and what we measured instead

I stopped treating a species list as a diagnosis, and I told him so plainly. Both organisms on his report are common in people who feel well. A name on a page says nothing about what his gut is doing. So we measured activity instead: breath hydrogen and methane, an inflammation marker and an honest record of a week of food. Then came three months of steady building. Fermentable plant food arrived most days, because that is what the good producers eat.

The next part of the series runs the other way, by taking away: the small bowel needs stretches of being empty while the colon needs feeding. When killing is truly needed, repopulating afterward is its own protocol. Every study and every number is gathered in the Deep Dive, with what each shows and what it cannot. It also has the questions to raise at your next appointment.

Frequently asked questions

Is a stool report that names a parasite worth acting on?

Accuracy is not the problem. Relevance is. A panel can correctly name organisms most healthy people carry. A fungal report matched the same person over time no better than it matched a stranger’s. A consensus statement from sixty-nine specialists found no proven clinical value in the consumer versions. Read a result as a question, not an instruction. Learning to read a claim before paying for it applies here too.

What does a low diversity score mean?

Less than the report implies. Diversity was not significantly linked to dying in a group of thousands. Adding the microbiome to ordinary clinical risk factors changed nothing at all. Richness also tracks stool firmness and transit speed. And it swings with the season in healthy people. Treat a low number as a prompt to look at fermentable food and drug exposure. The fuel your colon lining runs on is the more useful question.

Does a positive candida result mean I need an antifungal?

Usually it means you eat. In volunteers on a controlled diet, stool fungi traced back to the mouth or the plate. Brushing teeth more often lowered the candida signal. True fungal overgrowth happens after bacteria are lost, in people with weak immune systems. It looks nothing like a wellness printout. Bring the result to your physician, not to a protocol you bought. Testing well is a discipline of its own.

Can food rebuild the community without killing anything first?

That is the arm with better evidence behind it. Adding fermented food raised diversity and lowered 19 of 93 inflammatory proteins. Added fiber raised the community’s power to break down carbs instead. Both results were secondary to a null main result in a small trial. So read the direction, not the size. Neither arm needed an antimicrobial. A working gut community shows up in joints, not only in digestion.

How do I restore gut flora after antibiotics?

Slowly, and by feeding, not by buying a new community. Diversity stayed low for months after a single course. The butyrate makers took the worst of it. Probiotics tested against doing nothing delayed the return of a person’s own community. Their own banked stool restored it in days. Density comes from fiber arriving most days. What a monitor can and cannot tell you follows the same rule.

Sources

1. Cotter, J. M., Thomas, J., Birkholz, M., Ambroggio, L., Holstein, J., & Dominguez, S. R. (2021). Clinical impact of a diagnostic gastrointestinal panel in children. Pediatrics, 147(5), e2020036954. https://doi.org/10.1542/peds.2020-036954
2. Porcari, S., Mullish, B. H., Asnicar, F., Ng, S. C., Zhao, L., Hansen, R., O’Toole, P. W., Raes, J., Hold, G., Putignani, L., Hvas, C. L., Zeller, G., Koren, O., Tun, H., Valles-Colomer, M., Collado, M. C., Fischer, M., Allegretti, J., Iqbal, T., … Ianiro, G. (2025). International consensus statement on microbiome testing in clinical practice. The Lancet Gastroenterology & Hepatology, 10(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X
3. Auchtung, T. A., Fofanova, T. Y., Stewart, C. J., Nash, A. K., Wong, M. C., Gesell, J. R., Auchtung, J. M., Ajami, N. J., & Petrosino, J. F. (2018). Investigating colonization of the healthy adult gastrointestinal tract by fungi. mSphere, 3(2), e00092-18. https://doi.org/10.1128/mSphere.00092-18
4. Gabrielli, S., Furzi, F., Fontanelli Sulekova, L., Taliani, G., & Mattiucci, S. (2020). Occurrence of Blastocystis subtypes in patients from Italy revealed association of ST3 with a healthy gut microbiota. Parasite Epidemiology and Control, 9, e00134. https://doi.org/10.1016/j.parepi.2020.e00134
5. Asnicar, F., Berry, S. E., Valdes, A. M., Nguyen, L. H., Piccinno, G., Drew, D. A., Leeming, E., Gibson, R., Le Roy, C., Khatib, H. A., Francis, L., Mazidi, M., Mompeo, O., Valles-Colomer, M., Tett, A., Beghini, F., Dubois, L., Bazzani, D., Thomas, A. M., … Segata, N. (2021). Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nature Medicine, 27(2), 321-332. https://doi.org/10.1038/s41591-020-01183-8
6. Salosensaari, A., Laitinen, V., Havulinna, A. S., Meric, G., Cheng, S., Perola, M., Valsta, L., Alfthan, G., Inouye, M., Watrous, J. D., Long, T., Salido, R. A., Sanders, K., Brennan, C., Humphrey, G. C., Sanders, J. G., Jain, M., Jousilahti, P., Salomaa, V., … Niiranen, T. (2021). Taxonomic signatures of cause-specific mortality risk in human gut microbiome. Nature Communications, 12(1), 2671. https://doi.org/10.1038/s41467-021-22962-y
7. Vandeputte, D., Falony, G., Vieira-Silva, S., Tito, R. Y., Joossens, M., & Raes, J. (2016). Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut, 65(1), 57-62. https://doi.org/10.1136/gutjnl-2015-309618
8. Smits, S. A., Leach, J., Sonnenburg, E. D., Gonzalez, C. G., Lichtman, J. S., Reid, G., Knight, R., Manjurano, A., Changalucha, J., Elias, J. E., Dominguez-Bello, M. G., & Sonnenburg, J. L. (2017). Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania. Science, 357(6353), 802-806. https://doi.org/10.1126/science.aan4834
9. Wastyk, H. C., Fragiadakis, G. K., Perelman, D., Dahan, D., Merrill, B. D., Yu, F. B., Topf, M., Gonzalez, C. G., Van Treuren, W., Han, S., Robinson, J. L., Elias, J. E., Sonnenburg, E. D., Gardner, C. D., & Sonnenburg, J. L. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell, 184(16), 4137-4153.e14. https://doi.org/10.1016/j.cell.2021.06.019
10. Suez, J., Zmora, N., Zilberman-Schapira, G., Mor, U., Dori-Bachash, M., Bashiardes, S., Zur, M., Regev-Lehavi, D., Ben-Zeev Brik, R., Federici, S., Horn, M., Cohen, Y., Moor, A. E., Zeevi, D., Korem, T., Kotler, E., Harmelin, A., Itzkovitz, S., Maharshak, N., … Elinav, E. (2018). Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell, 174(6), 1406-1423.e16. https://doi.org/10.1016/j.cell.2018.08.047

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 18 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.